Innate Pharma

General information

117 Avenue de Luminy

13009 Marseille

Incorporated in: 1999/09/23

Number of employees: 80


More information

 

Main activity

Innate Pharma SA is a biopharmarceutical company developing first in class immunotherapy durgs for cancer and inflammatory diseases. The company specializes in development of new monoclonal antibodies targeting receptors and pathways controlling the activation of innate immunity cells.


Funding

Stock exchange listing: Euronext 2006 ISIN Code FR 0010331421 Ticket code IPH

Activities

Presentation of company's activity

Innate Pharma SA is a biopharmarceutical company developing first in class immunotherapy durgs for cancer and inflammatory diseases. The company specializes in development of new monoclonal antibodies targeting receptors and pathways controlling the activation of innate immunity cells.It has 2 priorietary clinical stage drug candidates : IPH 1101, a small molecule agonist of gamma delta T cells, has achieved proof of concept in 2 phases IIA trials in type C viral hepatitis and follicular lymphoma. IPH 2101, an anti-KIR monoclonal antibody potentiating NK cells activation, is currently in Phase II clinical trials in hematologic cancers. Innate Pharma is also developing a preclinical portfolio of immunomodulatory or cytotoxic monoclonal antibodies. Two of its preclinical programs in chronic inflammation have been out-licensed to Novo Nordisk A/S.
Innate Pharma ’s key expertise is in immunopharmacology and antibody technology. The Company has implemented in-house a large panel of molecular and cellular assays and in vivo models for assessing the pharmacodynamics and pharmacotoxicology of drug candidates. In addition, Innate Pharma has access to a very large set of unique research tools in cellular immunology through its worldwide network of scientific collaborations.
Incorporated in 1999 and listed on NYSE-Euronext in Paris in 2006, Innate Pharma is based in Marseilles, France, and had 85 employees as at December 31, 2010. Learn more about Innate Pharma at www.innate-pharma.com


En poursuivant votre navigation sur notre site, vous acceptez l'utilisation des cookies et la collecte de vos données et informations personnelles par Lyonbiopôle, dans les finalités de mesurer le trafic sur le site Web, de fournir des statistiques et de vous proposer des contenus adaptés à vos centres d’intérets. Pour exercer vos droits d'accès, de rectification, d'opposition, de suppression et de portabilité, conformément au règlement général sur la protection des données (UE n°2016/679), vous etes informés que vous pouvez envoyer votre demande à dpo@lyonbiopole.com. Plus de détails sont disponibles en cliquant ici J'accepte